Pralatrexate
Generic name: Pralatrexate
Brand names: Folotyn
Dosage form: intravenous solution (20 mg/mL)
Drug class:
Antimetabolites
Usage of Pralatrexate
Pralatrexate is used to treat T-cell lymphoma that has spread throughout the body.
Pralatrexate is usually given after other treatments have failed.
Pralatrexate may also be used for purposes not listed in this medication guide.
Pralatrexate side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Pralatrexate may cause serious side effects. Call your doctor at once if you have:
Common side effects of pralatrexate may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Pralatrexate
Tell your doctor if you have ever had liver or kidney problems.
You may need to have a negative pregnancy test before starting this treatment.
Pralatrexate can harm an unborn baby if the mother or the father is using pralatrexate.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
Relate drugs
- Adrucil
- Adrucil injection
- Alimta
- Arranon
- Clofarabine
- Clolar
- Cytarabine
- Cytarabine liposome
- Mylocel
- Capecitabine
- Cladribine
- Cladribine (Intravenous)
- Cladribine (Oral)
- Cladribine injection
- Dacogen
- Decitabine
- Depocyt
- Droxia
- Floxuridine
- Fludarabine (Intravenous)
- Fludarabine (Oral)
- Fludarabine injection
- Fluorouracil (Intravenous, Injection)
- Fluorouracil injection
- Folotyn
- FUDR
- Gemcitabine
- Gemzar
- Hydrea
- Hydroxyurea
- Infugem
- Leustatin
- Leustatin injection
- Mavenclad
- Mercaptopurine
- Nelarabine
- Oforta
- Pemetrexed
- Pemfexy
- Pralatrexate
- Purinethol
- Siklos
- Tabloid
- Thioguanine
- Xeloda
How to use Pralatrexate
Usual Adult Dose for Lymphoma:
Usual Adult Dose: 30 mg/m2 via intravenous push over 3 to 5 minutes once weekly for 6 weeks in 7 week cycles. Duration: Until disease progression or unacceptable toxicity.Comments: -Patients should take low dose (1 mg to 1.25 mg) oral folic acid daily. -Folic acid should start 10 days before the first dose of pralatrexate and continue for 30 days after the last dose.-Patients should also receive a B12 (1 mg) injection within 10 weeks before the first dose of pralatrexate and every 8 to 10 weeks thereafter. -Subsequent B12 injections may be given the same day as treatment with pralatrexate.Use: The treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Warnings
Pralatrexate can increase your risk of bleeding or infection. Call your doctor if you have unusual bruising or bleeding, or new signs of infection (fever, chills, body aches).
What other drugs will affect Pralatrexate
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may affect pralatrexate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions